Reports on the clinical trials for therapeutic DNA vaccines that will be conducted by PowderMed in 2004. Mechanism of action of therapeutic DNA vaccines; Tumor specific antigen used by PowderMed's cancer vaccine; Background on the company; Diseases to be targeted by the pre-clinical programs of the company.